University of California San Francisco
Give to UCSF
<p>The first U.S. meeting of the International AIDS Conference in more than two decades will be held later this month in Washington, DC, and Bay Area reporters got a preview of what UCSF researchers will present when they convene at the nation's capitol.</p>
Cancer patients across the country have a new way to navigate through difficult treatment decisions and communicate better with their doctors. “Open to Options,’’ which recently launched nationally, was developed in conjunction with UCSF to guide patients in making critical health decisions.
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.
<p>Vitamin D and calcium to prevent bone fractures in healthy, postmenopausal women does not work, at least at low supplemental doses, according to the United States Preventive Services Task Force.</p>
A new approach to drug design, pioneered by a group of researchers at UCSF and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects.
The single thing that a woman can do to lower her risk of breast cancer is to avoid unnecessary medical imaging, says Rebecca Smith-Bindman, MD, a professor of radiology and biomedical imaging, epidemiology and biostatistics at UCSF, who contributed to a new Institute of Medicine report.
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
To celebrate nearly a quarter-century of advances in hematology and transplantation, UCSF is holding a reunion of patients from the UCSF Medical Center who have undergone bone marrow transplants.
Malaria might be eliminated from countries it has plagued for centuries, according to malaria experts who gathered for the Bay Area World Malaria Day Symposium on April 25 at the UCSF Mission Bay campus.
In a study of patients 65 and older with non-small-cell lung cancer (NSCLC), younger patients were more likely to receive treatment than older patients, regardless of overall health and prognosis.
Funding cuts for malaria control are the single most common reason for the resurgence of the deadly disease, according to a new study that has linked overall weakened malaria control programs to the majority of global resurgences since 1930.
In honor of National Skin Cancer Awareness Month, the UCSF Department of Dermatology is offering free skin cancer screenings. The event is co-sponsored by Assemblyman Tom Ammiano, and San Francisco Supervisor Christina Olague.
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiform — which kills thousands of Americans every year.
